These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19520304)

  • 1. Atherogenesis and atherothrombosis--focus on diabetes mellitus.
    Stratmann B; Tschoepe D
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):291-303. PubMed ID: 19520304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy and vascular disease: an update.
    Buch MH; Prendergast BD; Storey RF
    Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):249-75. PubMed ID: 21303843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and thrombosis in diabetes.
    Hess K; Grant PJ
    Thromb Haemost; 2011 May; 105 Suppl 1():S43-54. PubMed ID: 21479339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
    Mafrici A; Proietti R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherothrombosis: a major health burden.
    Leys D
    Cerebrovasc Dis; 2001; 11 Suppl 2():1-4. PubMed ID: 11316915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
    Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
    Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin resistance and atherothrombotic disease.
    Mason PJ; Jacobs AK; Freedman JE
    J Am Coll Cardiol; 2005 Sep; 46(6):986-93. PubMed ID: 16168280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and thrombosis.
    Vazzana N; Ranalli P; Cuccurullo C; Davì G
    Thromb Res; 2012 Mar; 129(3):371-7. PubMed ID: 22197180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From atherosclerosis to atherothrombosis : from a silent chronic pathology to an acute critical event].
    Scheen AJ
    Rev Med Liege; 2018 May; 73(5-6):224-228. PubMed ID: 29926559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.
    Pepine CJ
    Ann Med; 2010; 42(1):19-35. PubMed ID: 20092398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis.
    Schäfer A; Bauersachs J
    Curr Vasc Pharmacol; 2008 Jan; 6(1):52-60. PubMed ID: 18220940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis.
    Tschoepe D; Roesen P; Schwippert B; Gries FA
    Semin Thromb Hemost; 1993; 19(2):122-8. PubMed ID: 8356457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of the complications of diabetes.
    Vinik AI; Vinik E
    Am J Manag Care; 2003 Mar; 9(3 Suppl):S63-80; quiz S81-4. PubMed ID: 12653455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.
    Zoungas S; Lui M; Kerr PG; Teede HJ; McNeil JJ; McGrath BP; Polkinghorne KR
    Intern Med J; 2011 Dec; 41(12):825-32. PubMed ID: 20298505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences.
    Viles-Gonzalez JF; Fuster V; Badimon JJ
    Eur Heart J; 2004 Jul; 25(14):1197-207. PubMed ID: 15246637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.